BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo H, Wang B, Xu K, Nie L, Fu Y, Wang Z, Wang Q, Wang S, Zou X. m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1. Front Oncol 2020;10:553045. [PMID: 33134163 DOI: 10.3389/fonc.2020.553045] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Li K, Gong Q, Xiang X, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang L, Zhou C, Wang Z, Zhuang L. HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis.. [DOI: 10.21203/rs.3.rs-2625457/v1] [Reference Citation Analysis]
2 Zheng R, Yu Y, Lv L, Zhang Y, Deng H, Li J, Zhang B. m(6)A reader HNRNPA2B1 destabilization of ATG4B regulates autophagic activity, proliferation and olaparib sensitivity in breast cancer. Exp Cell Res 2023;424:113487. [PMID: 36693492 DOI: 10.1016/j.yexcr.2023.113487] [Reference Citation Analysis]
3 Wu Q, Li G, Gong L, Cai J, Chen L, Xu X, Liu X, Zhao J, Zeng Y, Gao R, Yu L, Wang Z. Identification of miR-30c-5p as a tumor suppressor by targeting the m(6) A reader HNRNPA2B1 in ovarian cancer. Cancer Med 2023;12:5055-70. [PMID: 36259156 DOI: 10.1002/cam4.5246] [Reference Citation Analysis]
4 Zhu Y, Li J, Yang H, Yang X, Zhang Y, Yu X, Li Y, Chen G, Yang Z. The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. Cell Death Discov 2023;9:34. [PMID: 36707507 DOI: 10.1038/s41420-023-01321-4] [Reference Citation Analysis]
5 Shang QX, Kong WL, Huang WH, Xiao X, Hu WP, Yang YS, Zhang H, Yang L, Yuan Y, Chen LQ. Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method. Front Genet 2023;14:1079795. [PMID: 36733344 DOI: 10.3389/fgene.2023.1079795] [Reference Citation Analysis]
6 Shi J, Zhang Q, Yin X, Ye J, Gao S, Chen C, Yang Y, Wu B, Fu Y, Zhang H, Wang Z, Wang B, Zhu Y, Wu H, Yao Y, Xu G, Wang Q, Wang S, Zhang W. Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. Int J Biol Sci 2023;19:449-64. [PMID: 36632454 DOI: 10.7150/ijbs.76798] [Reference Citation Analysis]
7 Ge L, Huang P, Miao H, Yu H, Wu D, Chen F, Lin Y, Lin Y, Li W, Hua J. The new landscape of differentially expression proteins in placenta tissues of gestational diabetes based on iTRAQ proteomics. Placenta 2023;131:36-48. [PMID: 36473392 DOI: 10.1016/j.placenta.2022.11.012] [Reference Citation Analysis]
8 Hu T, Chen X, Lu S, Zeng H, Guo L, Han Y. Biological Role and Mechanism of Lipid Metabolism Reprogramming Related Gene ECHS1 in Cancer. Technol Cancer Res Treat 2022;21:15330338221140655. [PMID: 36567598 DOI: 10.1177/15330338221140655] [Reference Citation Analysis]
9 Zhou X, Zhang H, Duan Y, Zhu J, Dai H. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma. J Clin Lab Anal 2023;37:e24813. [PMID: 36525280 DOI: 10.1002/jcla.24813] [Reference Citation Analysis]
10 Zapata-García JA, Riveros-Magaña AR, Ortiz-Lazareno PC, Hernández-Flores G, Jave-Suárez LF, Aguilar-Lemarroy A. Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene. Diagnostics (Basel) 2022;12. [PMID: 36428851 DOI: 10.3390/diagnostics12112788] [Reference Citation Analysis]
11 Shu W, Xiao Y, Wang L, Liang M, Li Z, Wu X, Cao Q. Identification of an IGF2BP2-Targeted Peptide for Near-Infrared Imaging of Esophageal Squamous Cell Carcinoma. Molecules 2022;27:7609. [DOI: 10.3390/molecules27217609] [Reference Citation Analysis]
12 Zhen J, Pan J, Zhou X, Yu Z, Jiang Y, Gong Y, Ding Y, fang J, Liu Y, Huang D. FARSB Serves as a Novel Hypomethylated and Immune Cell Infiltration Related Prognostic Biomarker in Hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2171484/v1] [Reference Citation Analysis]
13 Teng C, Kong F, Mo J, Lin W, Jin C, Wang K, Wang Y. The roles of RNA N6-methyladenosine in esophageal cancer. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11430] [Reference Citation Analysis]
14 Li Y, Niu C, Wang N, Huang X, Cao S, Cui S, Chen T, Huo X, Zhou R. The Role of m6A Modification and m6A Regulators in Esophageal Cancer. Cancers 2022;14:5139. [DOI: 10.3390/cancers14205139] [Reference Citation Analysis]
15 Wu H, Xu H, Huang S, Tang Y, Tang J, Zhou H, Xie L, Qiao G. m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma. Front Oncol 2022;12:989817. [DOI: 10.3389/fonc.2022.989817] [Reference Citation Analysis]
16 Zhang H, Xia P, Yang Z, Liu J, Zhu Y, Dai C, Huang Z, Zhang Z, Yuan Y. CAND1 drives lipid metabolism and hepatocellular carcinoma progression by regulating FBXO11-mediated hnRNPA2B1 ubiquitination.. [DOI: 10.21203/rs.3.rs-2069215/v1] [Reference Citation Analysis]
17 Zheng H, Hua J, Li H, He W, Chen X, Ji Y, Li Q. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension. Front Genet 2022;13:974740. [DOI: 10.3389/fgene.2022.974740] [Reference Citation Analysis]
18 Tan L, Gao R, Chen X, Geng Y, Yin X, Chuan P, Mu X, Su Y, Zhang Y, Li F, He J. lincRNA RP24-315D19.10 promotes endometrial decidualization via upregulation of hnRNPA2B1.. [DOI: 10.1101/2022.09.07.506883] [Reference Citation Analysis]
19 Wang H, Zhang Y, Chen L, Liu Y, Xu C, Jiang D, Song Q, Wang H, Wang L, Lin Y, Chen Y, Chen J, Xu Y, Hou Y. Identification of clinical prognostic features of esophageal cancer based on m6A regulators. Front Immunol 2022;13:950365. [DOI: 10.3389/fimmu.2022.950365] [Reference Citation Analysis]
20 Cui M, Yi X, Cao Z, Zhu D, Wu J, Raghavamenon AC. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review. Journal of Oncology 2022;2022:1-27. [DOI: 10.1155/2022/4257359] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Akinlalu AO, Njoku PC, Nzekwe CV, Oni RO, Fojude T, Faniyi AJ, Olagunju AS. Recent developments in the significant effect of mRNA modification (M6A) in glioblastoma and esophageal cancer. Scientific African 2022;17:e01347. [DOI: 10.1016/j.sciaf.2022.e01347] [Reference Citation Analysis]
22 Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, Fu Y, Xu L, Xu K, Xu J, Xia A, Wang B, Xu G, Zou X, Su R, Kang W, Xue Y, Mo R, Sun B, Wang S. APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Adv Sci (Weinh) 2022;:e2201889. [PMID: 35975461 DOI: 10.1002/advs.202201889] [Reference Citation Analysis]
23 Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Int J Biol Sci 2022;18:4432-51. [PMID: 35864970 DOI: 10.7150/ijbs.73093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J, Feng J. Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. Cell Death Discov 2022;8:337. [PMID: 35879279 DOI: 10.1038/s41420-022-01129-8] [Reference Citation Analysis]
25 Zhang F, Liu H, Duan M, Wang G, Zhang Z, Wang Y, Qian Y, Yang Z, Jiang X. Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01304-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Cai X, Liang C, Zhang M, Xu Y, Weng Y, Li X, Yu W. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wang N, Huo X, Zhang B, Chen X, Zhao S, Shi X, Xu H, Wei X. METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer. Front Oncol 2022;12:861807. [PMID: 35574388 DOI: 10.3389/fonc.2022.861807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhang W, Xiao P, Tang J, Wang R, Wang X, Wang F, Ruan J, Yu S, Tang J, Huang R, Zhao X. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Front Immunol 2022;13:888650. [DOI: 10.3389/fimmu.2022.888650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Xue C, Chu Q, Zheng Q, Jiang S, Bao Z, Su Y, Lu J, Li L. Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine. Signal Transduct Target Ther 2022;7:142. [PMID: 35484099 DOI: 10.1038/s41392-022-01003-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
31 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Guo YQ, Wang Q, Wang JG, Gu YJ, Song PP, Wang SY, Qian XY, Gao X. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression. Exp Hematol Oncol 2022;11:14. [PMID: 35287752 DOI: 10.1186/s40164-022-00256-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Huang H, Cui X, Qin X, Li K, Yan G, Lu D, Zheng M, Hu Z, Lei D, Lan N, Zheng L, Yuan Z, Zhu B, Zhao J. Analysis and identification of m6A RNA methylation regulators in metastatic osteosarcoma. Mol Ther Nucleic Acids 2022;27:577-92. [PMID: 35036067 DOI: 10.1016/j.omtn.2021.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Jin L, Chen C, Yao J, Yu Z, Bu L. The RNA N(6) -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer. Clin Exp Pharmacol Physiol 2022;49:329-40. [PMID: 34717005 DOI: 10.1111/1440-1681.13608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z, Li W, Cai M. Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m(6)A Regulators. J Oncol 2022;2022:5490461. [PMID: 35069736 DOI: 10.1155/2022/5490461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer 2022;21:14. [PMID: 35022030 DOI: 10.1186/s12943-022-01500-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 26.0] [Reference Citation Analysis]
37 Shi X, Zhang J, Jiang Y, Zhang C, Luo X, Wu J, Li J. Comprehensive Analyses of the Expression, Genetic Alteration, Prognosis Significance, and Interaction Networks of m6A Regulators Across Human Cancers. Front Genet 2021;12:771853. [PMID: 35003212 DOI: 10.3389/fgene.2021.771853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Yu D, Pan M, Li Y, Lu T, Wang Z, Liu C, Hu G. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner. J Exp Clin Cancer Res 2022;41:6. [PMID: 34980207 DOI: 10.1186/s13046-021-02212-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
39 Li J, Liu H, Dong S, Zhang Y, Li X, Wang J. ALKBH5 Is Lowly Expressed in Esophageal Squamous Cell Carcinoma and Inhibits the Malignant Proliferation and Invasion of Tumor Cells. Comput Math Methods Med 2021;2021:1001446. [PMID: 34876920 DOI: 10.1155/2021/1001446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Zhu F, Yang T, Yao M, Shen T, Fang C. HNRNPA2B1, as a m6A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma. Front Oncol 2021;11:716921. [PMID: 34631545 DOI: 10.3389/fonc.2021.716921] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Cui M, Zhang M, Zhang L. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:421. [PMID: 34376206 DOI: 10.1186/s12935-021-02132-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Qin Z, Wang W, Ali MA, Wang Y, Zhang Y, Zhang M, Zhou G, Yang JD, Zeng C. Transcriptome-wide m6A profiling reveals mRNA post-transcriptional modification of boar sperm during cryopreservation. BMC Genomics 2021;22:588. [PMID: 34344298 DOI: 10.1186/s12864-021-07904-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Li L, Xie R, Wei Q. Network analysis of miRNA targeting m6A-related genes in patients with esophageal cancer. PeerJ 2021;9:e11893. [PMID: 34395102 DOI: 10.7717/peerj.11893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
44 Huang J, Shao Y, Gu W. Function and clinical significance of N6-methyladenosine in digestive system tumours. Exp Hematol Oncol 2021;10:40. [PMID: 34246319 DOI: 10.1186/s40164-021-00234-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
45 Maldonado López A, Capell BC. The METTL3-m6A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer. Genes (Basel) 2021;12:1019. [PMID: 34209046 DOI: 10.3390/genes12071019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
46 Li K, Chen J, Lou X, Li Y, Qian B, Xu D, Wu Y, Ma S, Zhang D, Cui W. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster. Front Cell Dev Biol 2021;9:658642. [PMID: 34277606 DOI: 10.3389/fcell.2021.658642] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
47 Cai Z, Niu Y, Li H. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility. Mol Hum Reprod 2021;27:gaab020. [PMID: 33749751 DOI: 10.1093/molehr/gaab020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
48 Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, Wang F. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Front Cell Dev Biol 2021;9:650023. [PMID: 33748145 DOI: 10.3389/fcell.2021.650023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]